The shares of this large-cap pharma stock engaged in the development and commercialization of a wide range of branded and generic formulations, API, and biotechnology products after the company reported a 72 percent year-on-year increase in net profits and revenue growth in its recently released quarterly results.  Share Price Movement  The share price of Lupin … Continue reading Pharma stock in green after net profit increases by 73% YoY in Sept Qtr